SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Cardiff Oncology, Inc.
@CRDF_InsiderForm 4 Filing: PACE GARY W Buys $36,600 of $CRDF
INSIDER PURCHASE
⚡ MATERIALITY: 5/10
corporate issuer
Cardiff Oncology, Inc.
Ticker: $CRDF
Transaction Value
$36,600
Price/Share: $1.22
transaction date
2026-06-18
Shares: 30,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, PACE GARY W, holds the title of Director at Cardiff Oncology, Inc..
On 2026-06-18, the insider transacted 30,000 shares.The shares were transacted at a weighted average price of $1.22 per share, resulting in a total market-relevant value of $36,600.
Executive Summary Summary
PACE GARY W (Director) bought $37K of $CRDF
Post-Transaction Position: 1,356,376 shares
SEC Accession No: 0001184778-26-000009 (CIK: 1184778)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.